,Magnitude,Repute,Summary
Rs2235015(G;G),0,Good,common/normal
Rs2235040(A;A),1.1,Good,"possibly higher chances of remission only for inpatients on certain antidepressants"
Rs2235040(A;G),1.1,Good,"possibly higher chances of remission only for inpatients on certain antidepressants"
Rs2235067(A;A),0,,
Rs2235067(A;G),0,,
Rs2235067(G;G),0,,
Rs2240017(G;G),0,Good,common
Rs2240340(A;A),1.5,Bad,"slightly increased (1.5x) risk for RA"
Rs2240340(A;G),1.5,Bad,"slightly increased (1.5x) risk for RA"
Rs2240340(G;G),0,Good,average
Rs2241524(C;C),0,Good,normal
Rs2241766(G;T),2,Good,"Slightly lower risk of breast cancer"
Rs2242480(C;C),0,Good,normal
Rs2243250(C;T),2,Good,"0.6x decreased risk for myocardial infarction if younger than 50"
Rs2243250(T;T),2,Good,"0.33x decreased risk for myocardial infarction if younger than 50"
Rs2250889(G;G),0,Good,"normal risk"
Rs2254958(C;C),1.5,Bad,"1.61x reported increased risk for Alzheimer's; however, see comments on main rs-page"
Rs2267012(G;G),0,Good,"normal risk"
Rs2267013(A;G),1.1,Bad,"1.3x increased risk for depression"
Rs2267013(G;G),1.2,Bad,"1.3x increased risk for depression"
Rs2269475(A;A),1.8,Bad,"increased rheumatoid arthritis risk"
Rs2269475(G;G),0,,normal
Rs2270641(G;G),2.1,Bad,"3.7x higher risk for schizophrenia"
Rs2270641(T;T),0,Good,normal
Rs2272382(G;G),0,Good,common/normal
Rs2273535(A;T),2,Bad,"slightly higher (~1.5x or less) risk for certain cancers"
Rs2278206(C;C),1.6,Good,"possibly less susceptible to asthma"
Rs2278206(T;T),1.8,Bad,"1.16x increased risk for asthma"
Rs2279420(T;T),0,Good,normal
Rs2279744(G;T),2,Bad,"Slightly more cancer prone; common"
Rs2280714(A;G),1.5,Bad,"1.4x increased risk of SLE"
Rs2280714(G;G),1,Good,"Normal risk of SLE"
Rs2295490(A;A),1,Good,normal
Rs2295490(A;G),1.3,Bad,"1.32x increased risk of early-onset type-2 diabetes"
Rs2295490(G;G),1.3,Bad,"1.32x increased risk of early-onset type-2 diabetes"
Rs2296336(G;G),0,Good,normal
Rs2300478(G;G),2,Bad,">1.7x risk for developing restless legs syndrome"
Rs2300478(G;T),1.5,Bad,"1.7x risk for developing restless legs syndrome"
Rs2302009(G;G),1.2,Bad,"4.6x risk of eosinophilic esophagitis"
Rs2304256(C;C),0.1,Bad,"1.6x increased risk for SLE"
Rs2305480(C;T),2,Bad,"3.5x increase in risk of asthma for Han Chinese"
Rs2306402(C;C),2.1,Bad,"1.18x increased risk for late-onset Alzheimer's disease"
Rs2306402(C;T),2,Bad,"1.18x increased risk for late-onset Alzheimer's disease"
Rs2306402(T;T),0,Good,normal
Rs2395029(G;T),3.2,Bad,"HLA-B*5701 carrier most likely (if Caucasian or Hispanic)"
Rs241448(C;T),2,Bad,"1.51x increased risk for Alzheimer's"
Rs2420946(T;T),2.1,Bad,"1.64x risk for breast cancer"
Rs2420946(C;T),2,Bad,"1.20x risk for breast cancer"
Rs242557(A;G),0,,normal
Rs242557(G;G),0,,
Rs242941(G;G),0,Good,"better response to inhaled corticosteroid in patients with COPD"
Rs2435357(A;A),1,Bad,"slightly higher (2x?) risk for Hirschsprung disease"
Rs2435357(A;G),0,,normal
Rs2435357(G;G),0,Good,normal
Rs2515475(C;C),0,,normal
Rs2515641(T;T),2,Bad,"CYP2E1_10463T>C(F421F) homozygote"
Rs2542151(G;G),2,Bad,"2x risk for Crohn's; 1.6x for T1D"
Rs2542151(G;T),1.3,Bad,"1.3x risk for Crohn's; 1.3x for T1D"
Rs25487(A;A),2,Good,"0.7x lower risk for skin cancer"
Rs25487(A;G),2,Bad,"2x higher risk for skin cancer; possibly other cancers"
Rs25487(G;G),2,Bad,"2x higher risk for skin cancer; possibly other cancers"
Rs2572886(A;G),2,Bad,"1.4x increased risk of HIV infection"
Rs2572886(A;A),2.1,Bad,"1.4x increased risk of HIV infection"
Rs2653349(G;G),1.1,Bad,"2-6x increased risk for cluster headaches"
Rs266729(C;G),1.8,Good,"0.73x decreased risk for colorectal cancer"
Rs266729(G;G),2,Good,"0.73x decreased risk for colorectal cancer"
Rs268(A;G),2,Bad,"3X increased risk for venous thromboembolism"
Rs27072(C;C),2,Bad,"2x risk of severe alcohol withdrawal. Possible increased odds of ADHD."
Rs2710102(T;T),2,,"Delayed childhood speech."
Rs27388(A;A),2,Bad,"Increased risk of developing schizophrenia"
Rs2802292(G;T),2,Good,"One copy of a longevity gene. Slightly increased lifespan."
Rs2802292(T;T),2.5,Bad,"Less likely to live to 100."
Rs2811712(G;G),2.1,Good,">1.5x less risk for physical impairment with age."
Rs2811712(A;G),2,Good,"1.5x less risk for physical impairment with age."
Rs2814707(A;A),1.2,Bad,">1.2x increased risk for ALS"
Rs2814707(A;G),1.2,Bad,"1.2x increased risk for ALS"
Rs2814707(G;G),0,Good,normal
Rs2814778(A;G),1,Good,Duffy-positive
Rs2814778(G;G),1,Good,"Duffy-negative, Fy(a-b-) phenotype; resistance to malaria;, increased odds of HIV infection upon exposure, but slowed disease progression if infected"
Rs283413(G;T),2.2,Bad,"3x higher risk for PD"
Rs28371685(T;T),2.5,Bad,"CYP2C9*11 homozygote"
Rs28371686(G;G),2.5,Bad,"CYP2C9*5 homozygote"
Rs2837960(G;G),2.3,Bad,"2.3x rheumatoid arthritis risk"
Rs28399424(C;T),2,,"carrier of one CYP1A2*6 allele"
Rs28399424(T;T),2,,"CYP1A2*6 homozygote"
Rs28694718(A;A),1.5,Bad,">2x higher risk for schizophrenia"
Rs28694718(A;G),1.5,Bad,"2x higher risk for schizophrenia"
Rs2881766(G;T),1.5,Bad,"Slightly increased risk for pregnancy-induced hypertension"
Rs2881766(T;T),1.5,Bad,"Slightly increased risk for pregnancy-induced hypertension"
Rs28897672(G;T),6,Bad,"considered a pathogenic BRCA1 breast cancer variant"
Rs28897696(A;C),6,Bad,"BRCA1 variant reported to be pathogenic for breast cancer"
Rs28897756(A;G),6,Bad,"considered a causal BRCA2 mutation for breast cancer"
Rs28940870(A;A),4,Bad,"type II hereditary angioedema"
Rs28940870(A;C),4.1,Bad,"Hereditary angioedema, type II"
Rs28942079(A;G),5,Bad,"Familial Hypercholesterolemia"
Rs2981582(C;T),3,Bad,"1.3x higher risk of ER+ breast cancer"
Rs2981582(T;T),3.2,Bad,"1.7x higher risk of ER+ breast cancer"
Rs30187(C;T),1.5,Bad,"1.4x higher risk for Ankylosing Spondylitis."
Rs30187(T;T),2,Bad,"2x higher risk for Ankylosing Spondylitis."
Rs3025786(C;C),1.6,Good,"slightly decreased Alzheimer's disease risk among ApoE4 carriers"
Rs3025786(C;T),1.6,Good,"slightly decreased Alzheimer's disease risk among ApoE4 carriers"
Rs3087243(G;G),1.5,Bad,"Increased risk for autoimmune diseases"
Rs3093061(A;A),0,Good,"normal risk"
Rs3095870(A;G),0.1,Bad,"1.7x increased risk for SLE (lupus)"
Rs312481(C;C),0,Good,"better response to certain calcium channel blockers"
Rs312481(C;T),0,,normal
Rs3129934(T;T),2.2,Bad,"3.3x increased risk for multiple sclerosis"
Rs3176336(A;A),0,Good,common/normal
Rs3176336(T;T),1.2,Bad,"Slightly higher (1.25x) higher risk for breast cancer"
Rs3184504(C;T),1.4,Bad,"Slightly increased risk for celiac disease"
Rs3184504(T;T),1.5,Bad,"slightly (1.4x) increased risk for celiac disease"
Rs3194051(A;G),1,Bad,"1.12x risk of type-1 diabetes"
Rs3194051(G;G),0,Good,normal
Rs3212227(A;A),1.5,Bad,"1.43x increased risk of developing psoriasis and psoriatic arthritis"
Rs3212227(A;C),2,Bad,"Significantly increased risk of developing cervical cancer"
Rs3212227(C;C),2,Bad,"Significantly increased risk of developing cervical cancer"
Rs3218005(A;A),0,Good,common/normal
Rs3218005(G;G),1.5,Bad,"Slightly higher (1.55x) risk for breast cancer"
Rs3218536(A;A),2,Good,"lower risk for breast, ovarian cancer"
Rs3218536(A;G),2,Good,"lower risk for breast, ovarian cancer"
Rs333(-;-),4,Good,"very resistant to HIV"
Rs333(-;GTCAGTATCAATTCTGGAAGAATTTCCAGACA),2,,"resistant to HIV"
Rs333(GTCAGTATCAATTCTGGAAGAATTTCCAGACA;GTCAGTATCAATTCTGGAAGAATTTCCAGACA),0,,"common form"
Rs33950507(A;A),4.5,Bad,"reduction in malarial risk; mild anemia"
Rs33950507(A;G),3,,"reduction in malarial risk; carrier of beta thalassemia mutation"
Rs34210653(T;T),2,Good,"Reduced risk for nasal polyps and chronic sinusitis"
Rs34330(C;T),1.3,Bad,"1.3x higher risk for endometrial cancer (in Chinese women)"
Rs34330(T;T),1.3,Bad,"1.2x higher breast cancer risk; 1.3x higher risk for endometrial cancer (in Chinese women)"
Rs34516635(G;G),1.1,Bad,"Less longevity for Ashkenazi Jewish women."
Rs34516635(A;G),1.5,Good,"Possibly increased longevity for Ashkenazi Jewish women."
Rs34516635(A;A),1.5,Good,"Possibly increased longevity for Ashkenazi Jewish women."
Rs35095275(A;A),6,Bad,"risk allele, but prone to genotyping confusion"
Rs35095275(A;G),3,,"carrier for parkinson's risk?"
Rs35095275(G;G),0,,"most common; unaffected"
Rs351855(C;T),2,Bad,"1.2x increased risk for prostate cancer"
Rs35600288(-;-),0,Good,"effects of higher bilirubin; irinotecan toxicity"
Rs35694136(T;T),0,Good,normal
Rs35859249(C;C),0,Good,normal
Rs358806(A;A),1,Good,"Normal risk of developing Type-2 diabetes"
Rs358806(A;C),1.5,Bad,"0.86x increased risk of developing Type-2 diabetes"
Rs3731239(C;T),0,Good,?
Rs3736228(C;T),1.3,Bad,"increased risk for osteoporosis"
Rs3736228(T;T),1.7,Bad,"increased risk for osteoporosis"
Rs3736309(A;G),2,Good,"0.44x decreased risk for chronic obstructive pulmonary lung disease"
Rs3736309(G;G),2,Good,"0.44x decreased risk for chronic obstructive pulmonary lung disease"
Rs3738414(G;G),0,,normal
Rs3738579(C;C),1.1,Bad,"0.6x decreased risk for cervical cancer, but 1.4x increased risk for HNSCC and 1.8x increased risk for breast cancer (reported in 2008)"
Rs3738579(C;T),1.1,Good,"0.5x decreased risk for cervical cancer, HNSCC, and breast cancer (reported in 2008)"
Rs3738579(T;T),1.1,Bad,"1.5x - 2x increased risk for cervical cancer, HNSCC, and breast cancer (reported in 2008)"
Rs3738919(C;C),2.5,Bad,"1.94x risk of developing rheumatoid arthritis"
Rs3738919(A;C),2,Bad,"1.94x risk of developing rheumatoid arthritis"
Rs3746444(C;C),2.1,Bad,"~1.2x increased risk for cancer"
Rs3746444(C;T),2,Bad,"~1.2x increased risk for cancer"
Rs3746444(T;T),2.1,Good,"decreased cancer risk"
Rs3748079(G;G),0.1,Bad,"1.9x increased risk for SLE (lupus)"
Rs3750817(C;T),2,Good,"0.78x reduced risk for breast cancer"
Rs3750817(T;T),2.4,Good,"0.64x reduced risk for breast cancer, and higher likelihood of favorable postmenopausal hormone therapy"
Rs3754777(A;A),1.5,Bad,"slightly higher blood pressure if Caucasian"
Rs3754777(G;G),0,Good,normal
Rs3758391(C;T),2,Good,"Less mental decline with age."
Rs3758391(T;T),2.4,Good,"Increased longevity. Less mental decline with age."
Rs3761847(A;G),2.1,Bad,"1.32 x risk of rheumatoid arthritis."
Rs3761847(G;G),2.2,Bad,">1.32 x risk of rheumatoid arthritis"
Rs3766379(C;C),0,,normal
Rs3768716(A;A),0,,normal
Rs3770748(T;T),0,,"average risk?"
Rs3782179(C;T),2,Good,"3x lower odds of testicular cancer risk for men"
Rs3783799(G;G),0,Good,"normal risk"
Rs3784709(C;T),1.5,Good,"0.71x risk of developing restless legs syndrome"
Rs3784709(T;T),1.8,Good,">0.71x risk of developing restless legs syndrome"
Rs3793784(C;G),2,Bad,"1.5x risk for ARMD"
Rs3794260(G;G),0,Good,average
Rs3798220(C;C),2.6,Bad,"2-3x higher risk for cardiovascular events, which can be lowered by aspirin"
Rs3798220(C;T),2.3,Bad,"2-3x higher risk for cardiovascular events, which can be lowered by aspirin"
Rs3802842(A;C),1.17,Bad,"1.17x increased risk of colorectal cancer"
Rs3802842(C;C),2,Bad,">1.17x increased risk of colorectal cancer"
Rs380390(G;G),0,,
Rs3804100(T;T),0,Good,normal
Rs3807153(C;T),1,Good,"carrier of a benign change"
Rs3813929(C;C),0,Bad,"possible weight gain if taking olanzapine"
Rs3814113(C;C),1.8,Good,"0.8x decreased risk for ovarian cancer"
Rs3814113(C;T),1.8,Good,"0.8x decreased risk for ovarian cancer"
Rs3814570(C;C),1,Good,"Normal risk of developing Crohn's disease"
Rs3814570(C;T),1.5,Bad,"1.3x increased risk for Crohn's disease with ileal involvement"
Rs3814570(T;T),1.5,Bad,"1.3x increased risk for Crohn's disease with ileal involvement"
Rs3817964(A;A),0,Good,normal
Rs3825776(A;G),1.5,Bad,"1.3x increased risk for ALS"
Rs3825776(G;G),2,Bad,">1.3x increased risk for ALS"
Rs3843763(C;C),1.6,Good,"Normal (higher) HDL ""Good"" Cholesterol."
Rs3843763(C;T),1.5,Bad,"Slightly lower HDL (""Good"") Cholesterol."
Rs3843763(T;T),1.9,Bad,"Slightly lower HDL (""Good"") Cholesterol."
Rs3849942(A;A),1.4,Bad,"1.4x increased risk for ALS"
Rs3849942(A;G),1.2,Bad,"1.2x increased risk for ALS"
Rs3849942(G;G),0,Good,normal
Rs3851179(A;A),1.5,Good,"0.85x decreased risk for Alzheimer's disease"
Rs3851179(A;G),1.5,Good,"0.85x decreased risk for Alzheimer's disease"
Rs3851179(G;G),0,Bad,normal
Rs3892097(G;G),0,Good,"extensive metabolizer"
Rs3923809(A;G),1.5,Bad,"Slightly increased risk of developing restless legs syndrome"
Rs3923809(G;G),1,Good,"Normal risk of developing restless legs syndrome"
Rs396991(G;G),0,,normal
Rs396991(T;T),0,Good,"complex; generally greater risk for cancer progression"
Rs401681(C;C),1.5,Bad,"~1.2x increased risk for several types of cancer"
Rs401681(C;T),1.5,Bad,"~1.2x increased risk for several types of cancer"
Rs4027132(A;A),2,Bad,"1.51x increased risk of developing bipolar disorder"
Rs4027132(A;G),1.5,Bad,"1.39x increased risk of developing bipolar disorder"
Rs403016(C;C),2,Good,normal
Rs403016(C;G),2,Bad,"2x risk for lupus"
Rs403016(G;G),2,Bad,"2x risk for lupus"
Rs41293455(C;T),6,Bad,"BRCA1 variant considered pathogenic for breast cancer"
Rs41293463(G;G),6,Bad,"BRCA1 variant considered pathogenic for breast cancer"
Rs41293463(G;T),6,Bad,"BRCA1 variant considered pathogenic for breast cancer"
Rs4148739(G;G),1,Good,"possibly, inpatients more likely to remit on certain antidepressants"
Rs4148739(A;G),1,Good,"possibly, inpatients more likely to remit on certain antidepressants"
Rs4148739(A;A),0,,"possibly normal probability of remission for inpatients on certain antidepressants"
Rs419788(A;A),1.5,Bad,"2.3x risk for lupus"
Rs419788(A;G),1.2,Bad,"2.0x risk for lupus"
Rs420259(T;T),1.5,Bad,"Normal risk of Bipolar Disorder."
Rs420259(C;C),1.9,Good,"Half the risk of developing Bipolar Disorder."
Rs4242382(A;A),2,Bad,"1.7x increased risk for prostate cancer"
Rs4242382(A;G),2,Bad,"1.7x increased risk for prostate cancer"
Rs4290(C;C),0,Good,normal
Rs4324715(C;T),1.1,Bad,"1.5x increased testicular cancer risk for men"
Rs4402960(G;T),2,Bad,"1.2x increased risk for type-2 diabetes, ~1x risk for gestational diabetes"
Rs4402960(T;T),2.1,Bad,"1.2x increased risk for type-2 diabetes, 1.5x risk for gestational diabetes"
Rs4420638(A;G),2,Bad,"~3x increased Alzheimer's risk; 1.4x increased heart disease risk ; increased LDL cholesterol"
Rs4430796(A;A),2.1,Bad,"1.38x increased risk for prostate cancer"
Rs4444903(A;A),0,Good,average
Rs4444903(G;G),2.1,Bad,"3.5x risk of hep-cancer in cirrhosis patients; higher glioma risk; 3x higher gallbladder cancer risk in females"
Rs4464148(C;C),2,Bad,"1.35x increased risk for colorectal cancer"
Rs4464148(C;T),1.5,Bad,"1.10x increased risk for colorectal cancer"
Rs4464148(T;T),1,Good,"Normal risk for colorectal cancer"
Rs4489954(T;T),1.8,Good,">0.69x risk of developing restless legs syndrome"
Rs4489954(G;T),1.5,Good,"0.69x risk risk of developing restless legs syndrome"
Rs4506565(A;A),0,Good,common/normal
Rs4506565(T;T),2,Bad,"1.9x increased risk for type-2 diabetes"
Rs45539432(C;T),3,Bad,"Carrier of an early-onset Parkinson's mutation"
Rs4626664(A;G),1.5,Bad,"1.44x increased risk of developing restless legs syndrome"
Rs4626664(A;A),2,Bad,">1.44x increased risk of developing restless legs syndrome"
Rs4633(C;C),0,Good,normal
Rs4633(T;T),2,Bad,"higher risk for endometrial cancer"
Rs4646438(-;-),0,Good,normal
Rs4648317(T;T),1.2,Bad,"prone to higher nicotine dependence, more impulsive/sensation seeking"
Rs4673(C;T),0,,normal
Rs4712653(C;C),1.6,Bad,"Slightly (~1.6x) increased risk for neuroblastoma"
Rs4712653(C;T),1.3,Bad,"very slightly (~1.3x) increased risk for neuroblastoma"
Rs4713902(C;C),0,Good,"0.47x decreased risk for bipolar disorder"
Rs4762(C;C),0,Good,"normal risk"
Rs4779584(T;T),2,Bad,"1.70x risk for colorectal cancer"
Rs4794067(C;C),2,,"2.1x risk for Aspirin Induced Asthma. But possibly lower risk of lupus and intractable Graves' disease."
Rs4794067(C;T),1.9,,"2.1x risk for Aspirin Induced Asthma. But possibly lower risk of intractible Grave's disease."
Rs4825476(G;G),2,Bad,
Rs4845618(G;T),1.5,Bad,"1.7x increased melanoma risk"
Rs486907(A;G),1.5,Bad,"1.5x increased prostate cancer risk"
Rs4911414(G;T),2,Bad,"2-4x higher risk of sun sensitivity if part of risk haplotype"
Rs4911414(T;T),2,Bad,"2-4x higher risk of sun sensitivity if part of risk haplotype"
Rs492602(C;C),1.5,,"Higher B12 levels in women"
Rs492602(C;T),1,Good,"Normal B12 levels"
Rs492602(T;T),1,Good,"Normal B12 levels"
Rs4934(G;G),0,Good,None
Rs4939827(C;C),1,Good,"0.73x decreased risk for colorectal cancer"
Rs4939827(C;T),1,Good,"0.86x decreased risk for colorectal cancer"
Rs4961(G;T),2,Bad,"1.8x increased risk for high blood pressure"
Rs4968451(A;C),2,Bad,"1.61x increased risk for meningioma"
Rs4968451(C;C),2.1,Bad,"2.33x increased risk for meningioma"
Rs4986907(G;G),0,Good,normal
Rs4988235(C;T),1.1,Good,"likely to be able to digest milk as an adult"
Rs4988235(T;T),1.1,Good,"can digest milk"
Rs4988321(A;A),1.3,Bad,"slightly increased (~1.3x) risk for osteoporosis"
Rs4988321(A;G),1.1,Bad,"very slightly increased risk for osteoporosis"
Rs501120(A;A),1.5,Bad,"common, but >1.3x increased risk for heart disease"
Rs501120(A;G),1.3,Bad,"1.3x increased risk for heart disease"
Rs5030655(-;T),2.1,,"possible CYP2D6 poor metabolizer phenotype"
Rs5030863(G;G),0,Good,normal
Rs5030865(A;C),2,,"carrier of one CYP2D6*8 inactive type allele"
Rs5030865(T;T),2,,"CYP2D6*14 inactive type homozygote"
Rs5030867(A;C),1.5,,"carrier of one CYP2D6*7 allele"
Rs5030867(C;C),4,,"CYP2D6*7 homozygote"
Rs5030882(C;C),1,,
Rs505922(C;C),2.1,Bad,"blood type is not O, increased risk for some diseases."
Rs505922(T;T),2,Good,"blood type O"
Rs5065(A;A),0,Good,"1.12x risk on diuretic; if hypertensive, better outcome when treated with calcium channel blocker than with diuretic"
Rs5174(A;G),2,Bad,"1.3x increased risk for heart disease"
Rs5186(C;C),3.8,Bad,"7.3x increased risk of hypertension"
Rs5186(A;C),2.1,Bad,"~1.4x increased risk of hypertension"
Rs520354(A;G),2,Bad,"increased risk in men for biliary conditions"
Rs520354(A;A),2,Bad,"increased risk in men for biliary conditions"
Rs527974(C;C),0,,
Rs527974(C;T),0,,
Rs527974(T;T),0,,normal
Rs5352(A;G),2.2,Bad,"probably Hirschsprung disease carrier"
Rs5370(G;T),1.2,Bad,"possibly lower HDL cholesterol in women"
Rs5443(C;T),2.1,Bad,"some risk"
Rs5443(T;T),2.4,Bad,"viagra is more likely to have an effect. increased metabolic disease risk."
Rs55785340(A;A),0,Good,normal
Rs55889066(G;G),0,Good,normal
Rs55901263(G;G),0,Good,normal
Rs55951658(T;T),0,Good,normal
Rs56276455(G;G),0,Good,normal
Rs56324128(C;C),0,Good,normal
Rs5743708(A;G),1.5,,"lower risk for Lyme; 1.6x higher risk of tuberculosis"
Rs5743708(G;G),0,Good,normal
Rs5746059(A;A),1.5,Bad,"Slightly higher fat mass"
Rs5746059(A;G),1.5,Bad,"Slightly higher fat mass"
Rs5751876(C;C),0,Good,None
Rs5751876(C;T),0,,None
Rs5882(A;G),2,Good,"Lower risk of dementia and Alzheimer's disease. Higher good cholesterol."
Rs5888(C;C),1.5,Good,"higher HDL cholesterol but lower risk for age-related macular degeneration"
Rs5888(T;T),2,,"lower HDL cholesterol but higher risk for age-related macular degeneration"
Rs5918(C;T),2,Bad,"MI risk, aspirin resistance"
Rs5984894(G;G),0,,normal
Rs599839(A;A),1.5,Bad,"1.4x increased risk for heart disease"
Rs599839(G;G),1.5,Good,"moderately lower (0.64x) risk for abdominal aortic aneurysm"
Rs6259(G;G),0,Good,"best inverse correlation between tea-drinking, soy-consuming premenopausal women and risk of endometrial cancer"
Rs6277(C;C),0,Bad,"1.6x higher schizophrenia risk"
Rs629242(T;T),2.1,Bad,"somewhat higher risk for prostate cancer"
Rs629242(C;T),2,Bad,"somewhat higher risk for prostate cancer"
Rs6314(C;C),0,Bad,"higher risk for RA"
Rs6314(T;T),0,,average
Rs6330(C;C),0,,"more anxious females, less anxious males"
Rs638405(G;G),2,Bad,"2x increased ALZ risk in ApoE4 carriers"
Rs6413438(C;T),2.3,,"carrier of one CYP2C19*10 allele"
Rs6413438(T;T),3,,"CYP2C19*10 homozygote"
Rs642961(A;A),2,Bad,"2.40x increased risk of cleft lip"
Rs642961(A;G),1.5,Bad,"1.68x increased risk of cleft lip"
Rs642961(G;G),1,Good,"Normal risk of cleft lip"
Rs6495446(C;C),1,Bad,"normal, but increased risk for chronic kidney disease"
Rs6495446(C;T),1.4,Good,"0.8x reduced risk for chronic kidney disease"
Rs6495446(T;T),2,Good,"0.64x reduced risk for chronic kidney disease"
Rs6498169(A;G),1.5,Bad,"1.14x risk of multiple sclerosis"
Rs6505162(A;A),2.1,Good,"0.43x decreased risk for esophageal cancer"
Rs6505162(A;C),2,Good,"0.58x decreased risk for esophageal cancer"
Rs6505162(C;C),1.5,Bad,normal
Rs6539137(T;T),0,Good,normal
Rs6601764(C;C),2,Bad,"1.52x increased risk of developing Crohn's disease"
Rs6601764(C;T),1.5,Bad,"1.16x increased risk of developing Crohn's disease"
Rs6603272(G;G),2,Bad,">2.74x increased risk of developing schizophrenia"
Rs6603272(G;T),2,Bad,"2.74x increased risk of developing schizophrenia"
Rs6603272(T;T),1,Good,"Normal risk of developing schizophrenia"
Rs663048(G;G),1,Good,"Normal risk of developing lung cancer"
Rs663048(G;T),2,Bad,"Significantly increased risk of developing lung cancer"
Rs664143(C;T),2.5,Bad,"Higher risk for number of cancers"
Rs664143(T;T),2.5,Bad,"Higher risk for number of cancers"
Rs6682654(A;A),0,,
Rs6700125(C;C),1,,"(No longer associated with ALS risk)"
Rs6700125(C;T),1,,"No longer thought to increase ALS risk"
Rs6700125(T;T),1,,"No longer thought to increase ALS risk"
Rs6710341(G;G),2,Bad,"Increased risk of developing restless legs syndrome"
Rs6710341(A;G),1.5,Bad,"Slightly increased risk of developing restless legs syndrome"
Rs6710341(A;A),1,Good,"Normal risk of developing restless legs syndrome"
Rs67784355(G;G),0,Good,normal
Rs6855911(A;A),2,Bad,"normal, but increased risk of gout"
Rs6855911(A;G),2,Good,"0.62x decreased risk for gout"
Rs6855911(G;G),2,Good,"rare, but 0.62x decreased risk for gout"
Rs6869366(T;T),0,Good,normal
Rs688034(C;T),1.1,Bad,"1.1x risk higher risk for coronary artery disease"
Rs6897876(C;T),1.1,Bad,"slight increase in testicular cancer risk for men"
Rs6897932(C;T),1.8,Good,"0.91x decreased risk for multiple sclerosis"
Rs6897932(T;T),2.1,Good,"0.70x decreased risk for multiple sclerosis"
Rs6908425(C;C),2,Bad,"1.95x increased risk of developing Crohn's disease"
Rs6920220(A;A),3.5,Bad,"1.7x risk of Rheumatoid Arthritis"
Rs6920220(A;G),3,Bad,"1.2x risk Rheumatoid Arthritis"
Rs6922269(A;A),2,Bad,"1.6x risk of coronary artery disease"
Rs693(C;C),0,Good,normal
Rs699(C;T),2,Bad,"increased risk of hypertension"
Rs699473(C;C),1.5,Bad,"~1.5x increased brain tumor risk"
Rs699473(C;T),1.5,Bad,"~1.5x increased brain tumor risk"
Rs699473(T;T),1,Good,"Normal brain tumor risk"
Rs700651(A;A),1,Good,"Normal risk of aneurysm"
Rs700651(A;G),1.5,Bad,"~1.11x increased risk of intracranial aneurysm"
Rs700651(G;G),2,Bad,"~1.23x increased risk of intracranial aneurysm"
Rs7014851(C;T),0,Good,"Very likely to be a benign allele"
Rs7101429(A;G),1.8,Good,"0.70x reduced risk for Alzheimer's risk"
Rs7101429(G;G),2,Good,"0.70x reduced risk for Alzheimer's risk"
Rs710521(G;G),2,Good,"Lower (0.83x) risk of developing bladder cancer."
Rs710521(A;G),1.5,,"Normal risk of developing bladder cancer."
Rs710521(A;A),2,Bad,"1.4x increased risk of developing bladder cancer."
Rs7216389(C;T),1.8,,"Normal risk for Childhood Asthma."
Rs7216389(T;T),2,Bad,"1.5x increased risk for Childhood Asthma."
Rs72547511(C;C),0,Good,normal
Rs72547513(A;C),2,,
Rs72547515(C;C),0,Good,normal
Rs72547516(A;A),0,Good,normal
Rs72547517(G;G),0,Good,normal
Rs72552799(C;C),0,Good,normal
Rs72558185(-;-),0,Good,normal
Rs72558186(T;T),0,Good,normal
Rs72558188(-;-),4,,"inactive CYP2C9"
Rs72558188(-;AGAAATGGAA),3,,"carrier of one CYP2C9*25 allele"
Rs72558188(AGAAATGGAA;AGAAATGGAA),0,Good,normal
Rs729302(A;A),1,Bad,"Normal risk of developing rheumatoid arthritis"
Rs729302(A;C),1.5,Good,"0.89x decreased risk of developing rheumatoid arthritis"
Rs729302(C;C),1.5,Good,"0.89x decreased risk of developing rheumatoid arthritis"
Rs7305115(A;A),0,Good,"Individuals showed a significantly lower risk of suicide behavior than those with the A/G or G/G genotype"
Rs733618(A;G),1.8,Bad,"1.87x risk for myasthenia gravis"
Rs7341475(A;A),0,,normal
Rs7341475(G;G),1.5,Bad,"1.58x increased schizophrenia risk for women"
Rs738409(C;C),3.1,Bad,"higher odds of alcoholic liver disease, increased liver fat"
Rs738409(C;G),2,Bad,"increased liver fat, odds of alcoholic liver disease"
Rs738409(G;G),2.1,Good,"most common genotype; slightly less damage from alcohol"
Rs7412(C;T),1,,"part of APOE4 genoset evaluation"
Rs743554(C;C),0,Good,normal
Rs7528684(G;G),1.2,Bad,"1.2x risk of Rheumatoid Arthritis; various risks of autoimmune diseases"
Rs7530511(T;T),2,Bad,"9x increased risk for Graves disease"
Rs7536563(A;A),2,Bad,">1.12x risk of multiple sclerosis"
Rs7536563(A;G),1.5,Bad,"1.12x risk of multiple sclerosis"
Rs7538876(A;A),2.1,Bad,"1.28x increased Basal Cell Carcinoma risk."
Rs7538876(A;G),1.8,,"Normal risk of Basal Cell Carcinoma."
Rs7568369(G;T),1.1,Good,"0.90x reduced risk of obesity"
Rs7568369(T;T),1.1,Good,"0.90x reduced risk of obesity"
Rs7574865(G;T),2.5,Bad,"1.3x risk of rheumatoid arthritis; 1.55x risk of SLE; 1.42x risk of Sjögren's syndrome; increased risk of type-1 diabetes; and increased risk of primary biliary cirrhosis."
Rs7574865(T;T),3.5,Bad,"1.69x risk of rheumatoid arthritis; 2.4x risk of SLE; 2.28x risk of Sjögren's syndrome; increased risk of type-1 diabetes; and increased risk of primary biliary cirrhosis."
Rs761100(G;G),1,Bad,"higher risk for dyslexia"
Rs761100(G;T),0,Good,"normal risk"
Rs761100(T;T),0,Good,"normal risk"
Rs762551(A;A),1.5,,"Faster caffeine metabolism in smokers and heavy coffee consumers"
Rs762551(A;C),0,,"Carrier of one CYP1A2*1F allele; Normal metabolism of caffeine"
Rs762551(C;C),0,,"Normal metabolism of caffeine."
Rs763110(C;T),2,Good,"~0.80x reduced cancer risk"
Rs763361(C;T),1.5,Bad,"Slightly increased risk for multiple autoimmune diseases, such as type-1 diabetes"
Rs763361(T;T),2,Bad,"Increased risk for multiple autoimmune diseases"
Rs7639618(C;T),2,Bad,"1.45x increased osteoarthritis risk"
Rs7639618(T;T),2,Bad,"1.45x increased osteoarthritis risk"
Rs7652331(T;T),0,Bad,"somewhat higher risk for prostate cancer"
Rs7787082(G;G),0,,
Rs7794745(A;T),2,Bad,"slightly increased risk for autism"
Rs7807268(C;G),2,Bad,"1.3x risk for Crohn's disease"
Rs7837688(G;T),2.1,Bad,"1.7x increased risk for prostate cancer"
Rs7837688(T;T),2.1,Bad,"1.7x increased risk for prostate cancer"
Rs7923837(A;G),1.9,Bad,"1.6x risk for T2D"
Rs7997012(A;A),0,Good,"~18% more likely to respond to citalopram"
Rs800292(C;T),1,Good,"1% decreased risk of macular degeneration"
Rs801114(G;G),2.1,Bad,"1.28x increased Basal Cell Carcinoma risk."
Rs801114(G;T),1.8,Bad,"Normal (slightly higher) risk of Basal Cell Carcinoma."
Rs801114(T;T),2,Good,"0.78x decreased Basal Cell Carcinoma risk."
Rs8034191(C;C),2.6,Bad,"1.80x lung cancer risk; decreased response to alcohol"
Rs8034191(C;T),2.5,Bad,"1.27x lung cancer risk"
Rs8055236(G;T),1.7,Bad,"1.9x risk for heart disease"
Rs807701(C;T),1.5,Bad,"Slightly increased dyslexia risk"
Rs807701(T;T),1,Good,"Normal dyslexia risk"
Rs8176058(C;T),1.4,,"KELL Blood group; K/k heterozygote"
Rs8176058(T;T),2.5,,"KELL blood group; K antigen (K/K)"
Rs8179183(C;G),1,Good,"less likely to gain weight if taking risperidone"
Rs8179183(G;G),1,Good,"less likely to gain weight if taking risperidone"
Rs8192466(C;T),2.5,,"uncertain, probably harmless"
Rs828907(G;G),1,Good,"Normal risk of developing bladder cancer"
Rs828907(G;T),2,Bad,"Slightly increased risk of bladder cancer and 2x risk of developing bladder cancer in smokers"
Rs828907(T;T),2,Bad,"Increased risk of bladder cancer and 2x risk of developing bladder cancer in smokers"
Rs851715(A;A),1.2,Bad,"risk of nonsense-word repetition problems if speech-impaired"
Rs851715(A;G),0.1,,None
Rs851715(G;G),0.1,,None
Rs854560(A;T),2,Bad,"higher risk for heart disease, diabetic retinopathy"
Rs854560(T;T),1.8,Good,"0.5x lower risk of ovarian cancer"
Rs855791(T;T),0,Bad,"0.2 g/dL lower hemoglobin on average"
Rs915909(T;T),0,Good,"CYP2E1_6498C>T(I321I) homozygote"
Rs9332131(-;-),2.5,Bad,"CYP2C9*6 homozygote"
Rs9332739(C;G),2.1,Good,"0.47x decreased risk for AMD"
Rs9332964(A;G),2.5,Bad,"carrier for mutations linked to micropenis"
Rs9402571(G;G),1.8,Good,"0.85x decreased risk for type-2 diabetes"
Rs9402571(G;T),1.4,Good,"slightly decreased risk for type-2 diabetes"
Rs944289(C;C),0,Good,
Rs944289(C;T),2.1,Bad,"1.3x increased thyroid cancer risk"
Rs944289(T;T),2.2,Bad,"1.69x increased thyroid cancer risk"
Rs9561778(G;G),1,Good,"Normal risk of adverse drug reactions from cyclophosphamide treatments"
Rs9561778(G;T),1.5,Bad,"~2x increased risk of adverse drug reactions from cyclophosphamide treatments"
Rs9561778(T;T),1.5,Bad,"~2x increased risk of adverse drug reactions from cyclophosphamide treatments"
Rs9642880(G;T),1.5,Bad,"1.2x increased bladder cancer risk"
Rs9642880(T;T),2,Bad,"1.5x increased bladder cancer risk"
Rs9652490(A;A),2,Bad,"~2x increased risk for Parkinson's disease, and, essential tremor"
Rs9652490(A;G),1.5,Bad,"Slightly increased risk of developing Parkinson's Disease"
Rs9652490(G;G),1,Good,"Normal risk of developing Parkinson's Disease"
Rs965513(A;A),2,Bad,"3.1x increased thyroid cancer risk"
Rs965513(A;G),2,Bad,"1.77x increased thyroid cancer risk"
Rs965513(G;G),0.1,Good,normal
Rs966221(C;C),1.5,Bad,"1.5x increased stroke risk certain populations"
Rs9858542(A;A),1.3,Bad,"1.8x risk of Crohn's disease"
Rs9858542(A;G),1.2,Bad,"1.1x risk Crohn's Disease"
Rs9864422(C;C),0,Good,normal
Rs987525(A;A),2,Bad,"6x increased risk for cleft lip"
Rs987525(A;C),1,Bad,"2.5x increased risk for cleft lip"
Rs987525(C;C),0,Good,normal
Rs9886784(A;A),1.5,Bad,"mixed evidence of Alzheimer's disease risk"
Rs9951307(A;G),0,Good,"0.10 decreased risk for brain edema after a stroke"
Rs997669(G;G),1.1,Bad,"Very slightly increased (1.18x) increased breast cancer risk"
Rs8187710(G;G),0,Good,"common on affy axiom data"
Rs1136201(A;A),0,Good,"common in clinvar"
Rs58597806(G;G),0,Good,normal
Rs58597806(G;T),1.8,,"likely reduced UGT1A9 glucuronidation"
Rs58597806(T;T),2,,"likely reduced UGT1A9 glucuronidation"
Rs6791924(G;G),0,Good,"common in complete genomics"
Rs1801086(G;G),0,Good,"common in complete genomics"
Rs1800172(G;G),0,Good,"common in complete genomics"
Rs2234916(A;A),0,Good,"common in complete genomics"
Rs2228145(A;A),0,Good,"common in clinvar"
Rs36210421(G;G),0,Good,"common in complete genomics"
Rs35350960(C;C),0,Good,"common in clinvar"
Rs1021737(G;G),0,Good,"common in clinvar"
Rs1021737(T;T),3,Bad,"significantly higher plasma total homocysteine concentration"
Rs5742905(T;T),0,Good,"common in clinvar"
Rs5742905(C;C),3.5,Bad,"possible miscall in Ancestry V2.0 datasets; otherwise, Mild clinical homocystinuria which is responsive to vitamin B6"
